{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 1323"}, "official-title": {"#tail": "\n\t", "#text": "To address the continued threat posed by dangerous\n\t\t  synthetic drugs by amending the Controlled Substances Act relating to\n\t\t  controlled substance analogues."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130718", "#text": "July 18, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSJU00", "#text": "Committee on the\n\t\t\t Judiciary"}, "sponsor": {"#tail": " (for\n\t\t\t herself, ", "#text": "Mrs. Feinstein", "@name-id": "S221"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Ms. Klobuchar", "@name-id": "S311"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Manchin", "@name-id": "S338"}, {"#tail": ") introduced the following\n\t\t\t bill; which was read twice and referred to the\n\t\t\t ", "#text": "Mr. Schumer", "@name-id": "S270"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Protecting Our Youth from\n\t\t\t Dangerous Synthetic Drugs Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Enforcement"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Controlled\n\t\t\t Substances Act", "@value": "Controlled Substances Act"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 801 et seq.", "@value": "usc/21/801/etseq"}, "@parsable-cite": "usc/21/801", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", by striking ", "@entity-type": "act", "#text": "section\n\t\t\t 102(32)", "@value": "Controlled Substances Act/s:102/p:32"}, {"#tail": " and inserting the following:", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Controlled Substances Act/s:102/p:32/sp:A"}], "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": ";\n\t\t\t\tand"}, "#tail": "\n\t\t\t\t", "@id": "id2C61F76770744B8F9EC25D17CF2EFA42", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "subparagraph": {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(C)", "@value": "Controlled Substances Act/s:102/p:32/sp:C"}, "term": {"#tail": " means\u2014", "#text": "controlled substance analogue"}, "#text": "Except as provided in "}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a substance whose chemical\n\t\t\t\tstructure is substantially similar to the chemical structure of a controlled\n\t\t\t\tsubstance in schedule I or II\u2014"}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "which has a stimulant, depressant, or\n\t\t\t\thallucinogenic effect on the central nervous system that is substantially\n\t\t\t\tsimilar to or greater than the stimulant, depressant, or hallucinogenic effect\n\t\t\t\ton the central nervous system of a controlled substance in schedule I or II;\n\t\t\t\tor"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "idf9841faaa1b4449fb0a326a948685607", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "with respect to a particular person,\n\t\t\t\twhich such person represents or intends to have a stimulant, depressant, or\n\t\t\t\thallucinogenic effect on the central nervous system that is substantially\n\t\t\t\tsimilar to or greater than the stimulant, depressant, or hallucinogenic effect\n\t\t\t\ton the central nervous system of a controlled substance in schedule I or II;\n\t\t\t\tor"}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "idea562de49ca44e12b812df0c5c006f43", "#text": "\n                  "}], "#text": "\n                ", "@id": "idf797eedc4a244152823c7ed913ec5844"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " in\n\t\t\t\taccordance with ", "@entity-type": "federal-body", "#text": "Controlled Substance Analogue Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 201(i)", "@value": "Controlled Substances Act/s:201/ss:i", "@proposed": "true"}], "#text": "a substance designated as a\n\t\t\t\tcontrolled substance analogue by the "}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "@id": "idC734FB73A297402E86508E1A8FF0E411", "#text": "\n                "}], "#text": "\n              ", "@id": "id7D4F2F94B88246E7850ADB9F2D896A1B"}}, "#text": "\n          ", "@id": "id6070A89960754965B7F282986FFEF307"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t by adding at the end the following:", "@entity-type": "act", "#text": "section 201", "@value": "Controlled Substances Act/s:201"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "#text": "\n              ", "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "id60CF5AB3377F43EEAA7D39B7D8467108", "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tin consultation with the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ", shall\n\t\t\t\testablish an interagency committee, to be known as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " (referred to in this subsection as the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Controlled Substance\n\t\t\t\tAnalogue Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "The ", "quote": {"#tail": ").", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "\n                    "}}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "id908D960EC0D04866843BA45AFBD19D4C", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\u2014", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "idF9DBB534CAC6457988FBD7CF6C778182", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Administrator of the\n\t\t\t\tDrug Enforcement Administration", "@entity-id": "1524"}, "#text": "headed by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id7C3D94F6BB2043B7856DBAD9A712DCC5", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "comprised of scientific experts in the\n\t\t\t\tfields of chemistry and pharmacology from\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Drug Enforcement\n\t\t\t\tAdministration", "@entity-id": "1524"}, "#text": "the "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id69F1DD4CE43B4A9E9D96F9F6304C9480", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Institute on Drug\n\t\t\t\tAbuse", "@value": "National Institute on Drug Abuse"}, "#text": "the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id7B5D5C1B8F7A40C79759E36B5F133F88", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Centers for\n\t\t\t Disease Control and Prevention", "@entity-id": "7523"}, "#text": "the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id2ACC7910DE75466C84973BABD1AFEDE7", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in consultation with the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ", to be appropriate.", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t\tHealth and Human Services", "@entity-id": "7500"}], "#text": "any other Federal agency\n\t\t\t\tdetermined by the "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "id783F7D4DB6584DCEBAC5D13F5D21A753", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id37453C3B7B554845A40E98AB13195BB4"}]}, {"@indent": "up1", "#tail": "\n              ", "@id": "id49483F5929534D5D9A71A88A7CB198E3", "enum": {"#tail": "\n                ", "#text": "(3)"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tconvene, on an as needed basis, to establish and maintain a list of controlled\n\t\t\t\tsubstance analogues.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "id8B3379C9D38C4268A8D2180952B0BAC8", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under this subsection if the\n\t\t\t\tsubstance is determined by the ", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": " to be similar to a schedule I or II\n\t\t\t\tcontrolled substance in either its chemical structure or its predictive effect\n\t\t\t\ton the body, in such a manner as to make it likely that the substance will, or\n\t\t\t\tcan be reasonably expected to have a potential for abuse.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "A substance may be designated as a\n\t\t\t\tcontrolled substance analogue by the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "idA9EEC7AC3B484016A93E8EFAED132224"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Evidence of human consumption by an\n\t\t\t\tindividual or the public at large is not necessary before a substance may be\n\t\t\t\tdesignated as a controlled substance analogue under this subsection."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "idA86F7E8D431B450FAB2D5B391350A864"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall, through\n\t\t\t\trulemaking, establish procedures of operation for the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "#text": "\n                  ", "@id": "idB9CE377AA1054503A7D4F2EF806A0EC8"}]}, {"@indent": "up1", "#tail": "\n              ", "@id": "idAEDFE182C04E4847B7220D26B7554D49", "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "subparagraph": [{"@display-inline": "yes-display-inline", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": " shall submit to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " a notice of the meeting of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", which shall include\u2014", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "Not later than 30 days\n\t\t\t\tbefore each meeting of the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " during the meeting for designation as a controlled\n\t\t\t\tsubstance analogue; and", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "a list of the substances to be\n\t\t\t\tconsidered by the "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id87457440C7C3456C86EC0A083ED61249"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to make a determination of whether an exemption or approval\n\t\t\t\tfor each substance listed under ", "@entity-type": "federal-body", "#text": "Secretary of Health\n\t\t\t\tand Human Services", "@entity-id": "7500"}, {"#tail": " is in effect under ", "@entity-type": "act", "#text": "clause (i)", "@value": "Controlled Substances Act/s:201/ss:i/p:4/sp:A/cl:i", "@proposed": "true"}], "#text": "a request for the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505 of\n\t\t\t\tthe Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "@entity-type": "law-citation", "#text": "\n                        ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "uscode", "#text": "21 U.S.C. 355", "@value": "usc/21/355"}, "@parsable-cite": "usc/21/355", "#text": "\n                          ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "id13B76B37763347808D7020478E68A147"}], "#text": "\n                  ", "@id": "id834FE493F4BD4600BFC2636C4DA67DC8", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " receives notice under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Controlled Substances Act/s:201/ss:i/p:4/sp:A", "@proposed": "true"}, {"#tail": " shall submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " a written\n\t\t\t\tresponse to the request described under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ". The ", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Controlled Substances Act/s:201/ss:i/p:4/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "\n\t\t\t\tshall consider the response submitted by the ", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": " in determining whether to designate a substance considered by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t\tServices", "@entity-id": "7500"}, {"#tail": " at the meeting as a controlled substance analogue.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "Not later than 30 days after the date\n\t\t\t\ton which the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "id87ABA88FB00C421ABDE553CDD4941087"}]}, {"@indent": "up1", "#tail": "\n              ", "@id": "idA8073704B72A49C18B8F7853FA7686CA", "enum": {"#tail": "\n                ", "#text": "(5)"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall publish in the Federal Register any designation made by the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": "\n\t\t\t\tunder this subsection.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "id57DF259EB1314BF999ECBEDE1FD0185E", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publish, on the website of the Drug\n\t\t\t\tEnforcement Administration, a description of each designation made by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Administrator of the Drug\n\t\t\t\tEnforcement Administration", "@entity-id": "1524"}, {"#tail": " under this subsection, which shall include\u2014", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the chemical and common name of the\n\t\t\t\tcontrolled substance analogue;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id8405A18A419B4061B678D6120ACCEF18", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (6)(A)", "@value": "Controlled Substances Act/s:201/ss:i/p:6/sp:A", "@proposed": "true"}, "#text": "the effective date of the\n\t\t\t\tdetermination, as described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idF904CB65FDDB4A95A2A3D0595D377E38", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has determined a substance is an analogue\n\t\t\t\tof.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "any schedule I or II controlled\n\t\t\t\tsubstance that the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id0F42916BE9644882B6DFE9CE1F35257C", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id6B4D22FCBB12484E8A116CD4B3236ED8"}]}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tunder this subsection shall take effect on the date that is 30 days after the\n\t\t\t\tdate on which the designation is published in the Federal Register under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (5)(A)", "@value": "Controlled Substances Act/s:201/ss:i/p:5/sp:A", "@proposed": "true"}], "#text": "A designation made by the "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "#text": "\n                ", "@id": "idA06C8D818F6A43CF91BFA245B5AB1BA5"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under this section is\n\t\t\t\tsubsequently scheduled through a rulemaking proceeding under ", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, {"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Controlled Substances Act/s:201/ss:a"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(d)", "@value": "Controlled Substances Act/s:201/ss:d"}, {"#tail": ", the substance shall be automatically removed from the controlled\n\t\t\t\tsubstance analogue list.", "@entity-type": "act", "#text": "(h)", "@value": "Controlled Substances Act/s:201/ss:h"}], "#text": "If a substance designated as a\n\t\t\t\tcontrolled substance analogue by the "}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "#text": "\n                ", "@id": "idE4C9408110154D5B94DABED3DD12EEE3"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " under this\n\t\t\t\tsubsection the issue shall be considered a question of\n\t\t\t\tlaw.", "@entity-type": "federal-body", "#text": "Committee", "@value": "Controlled Substance Analogue Committee", "@proposed": "true"}, "#text": "If a defendant challenges the\n\t\t\t\tdesignation of a controlled substance analogue made by the "}, "enum": {"#tail": "\n                ", "#text": "(8)"}, "#text": "\n                ", "@id": "idF8B183CE1D244102B58B4704896981A8"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id7B6AF1540A124392B0D33FA7AF212DDE"}, "#text": "\n          ", "@id": "id1D2055D80BD8433EB8F8CD57346A4176"}], "#text": "\n        ", "@id": "idC6D5B00BD4FA4C1C9695E21D268663A3"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " after\n\t\t\t ", "#text": "controlled substance analogues,"}, {"#tail": ".", "#text": "substances,"}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "public-law", "#text": "Section\n\t\t\t 111(b)(2)(B) of ", "external-xref": {"#tail": "\n            ", "@parsable-cite": "pl/102/395", "#text": "Public Law 102\u2013395", "@legal-doc": "public-law"}, "@value": "public-law/102/395/s:111/ss:b/p:2/sp:B"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 886a(2)(B)", "@value": "usc/21/886a//2/B"}, "@parsable-cite": "usc/21/886a", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Funding"}, "#text": "\n        ", "@id": "id2F8305E0FC9F4EB6BD03E5AE39CDED93"}], "#text": "\n      ", "@id": "id2008687D63C540DEB0E696A58A9274EC"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1002 of the Controlled Substances\n\t\t\t Import and Export Act", "@value": "Controlled Substances Import and Export Act/s:1002"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 952", "@value": "usc/21/952"}, "@parsable-cite": "usc/21/952", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Importation of\n\t\t\t controlled substance analogues"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "subsections (c) through (e)", "@value": "Controlled Substances Import and Export Act/s:1002/ss:c..e"}, {"#tail": ", respectively;\n\t\t\t and", "@entity-type": "act", "#text": "subsections (d) through (f)", "@value": "Controlled Substances Import and Export Act/s:1002/ss:d..f", "@proposed": "true"}], "#text": "by redesignating\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id6E7D2014487A4E858B46EEE686FB3D9E", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following:", "@entity-type": "act", "#text": "subsection (b)", "@value": "Controlled Substances Import and Export Act/s:1002/ss:b"}, "#text": "by inserting\n\t\t\t after "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may by regulation\n\t\t\t\tprescribe.", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "It shall be\n\t\t\t\tunlawful to import into the customs territory of the United States from any\n\t\t\t\tplace outside thereof (but within the United States), or to import into the\n\t\t\t\tUnited States from any place outside thereof, any controlled substance analogue\n\t\t\t\tdesignated pursuant to ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " unless the controlled substance analogue is imported pursuant to\n\t\t\t\tsuch notification or declaration as the ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 201(i) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:201/ss:i"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t\tU.S.C. 811(i)", "@value": "usc/21/811/i"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "@id": "id3140211C4EB94886B5545955453D3892", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id0B4C051427E640B78CE83A89D83E8785"}, "#text": "\n        ", "@id": "idA50648C2207F4DD9960B77B1559272EB"}], "#text": "\n      ", "@id": "id19FBADED53A04E67983F0B36F1D8DDBF"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Directive to\n\t\t\t Sentencing Commission"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "uscode", "#text": "\n            ", "external-xref": {"#tail": " of title 28,\n\t\t\t United States Code", "@parsable-cite": "usc/28/994", "#text": "section 994", "@legal-doc": "usc"}, "@value": "usc/28/994"}, {"#tail": " shall review and,\n\t\t\t if appropriate, amend the Federal sentencing guidelines and policy statements\n\t\t\t to ensure the guidelines and policy statements provide adequate penalties for\n\t\t\t any offense involving the unlawful manufacturing, importing, exporting, or\n\t\t\t trafficking of controlled substance analogues under ", "@entity-type": "federal-body", "#text": "United States Sentencing Commission", "@entity-id": "1030"}], "#text": "Pursuant to its authority under ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part D of the Controlled\n\t\t\t Substances Act", "@value": "Controlled Substances Act/pt:D"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 841 et seq.", "@value": "usc/21/841/etseq"}, "@parsable-cite": "usc/21/841", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": " and similar offenses, including\n\t\t\t unlawful possession, possession with intent to commit any of the foregoing\n\t\t\t offenses, and attempt and conspiracy to commit any of the foregoing\n\t\t\t offenses.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part A of the Controlled Substances\n\t\t\t Import and Export Act", "@value": "Controlled Substances Import and Export Act/pt:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 951 et seq.", "@value": "usc/21/951/etseq"}, "@parsable-cite": "usc/21/951", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "#text": "\n        ", "@id": "id6417b965150f414aa84a26bef1855cce"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t shall\u2014", "@entity-type": "federal-body", "#text": "Sentencing Commission", "@entity-id": "1030"}, "#text": "In carrying out this section, the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Commission\n\t\t\t duties"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "ensure that the\n\t\t\t sentences, guidelines, and policy statements relating to offenders convicted of\n\t\t\t these offenses are appropriately severe and reasonably consistent with other\n\t\t\t relevant directives and other Federal sentencing guidelines and policy\n\t\t\t statements;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "id971e86a1c9a1490c94113f95c210c410", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "make any\n\t\t\t necessary conforming changes to the Federal sentencing guidelines; and"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "id53409e810ce8433f991cbe1950be73d0", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "uscode", "#text": "section\n\t\t\t 3553(a)(2) of title 18, United States Code", "@value": "usc/18/3553/a/2"}, "#text": "assure that the\n\t\t\t guidelines adequately meet the purposes of sentencing as set forth in "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "id6564fda7336f4697a4b6b2f3992f019f", "#text": "\n          "}], "#text": "\n        ", "@id": "id140980dd568344f19ebf490454814ff7"}], "#text": "\n      ", "@id": "id0051B7FD54E34DB2A2FF16422F4B778B"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-07-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S1323 IS: Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}